Navigation Links
Anacor Clinical Study of AN2728, a Novel Anti-Inflammatory,Compound, Shows Efficacy in Psoriasis

- Topical Therapy Reduces TNF-alpha Production Through Inhibition of PDE-4 Enzyme

PALO ALTO, Calif., June 06, 2007 /PRNewswire/ -- Anacor Pharmaceuticals, a privately held pharmaceutical company, announced today the results from its placebo-controlled Phase 1 trial of AN2728, a first-in-class topical therapy under investigation for the treatment of psoriasis. The trial showed AN2728 to be well-tolerated, with activity comparable to existing topical treatments for psoriasis.

AN2728 is the product of a focused medicinal chemistry effort to create small molecules that inhibit TNF-alpha, the inflammatory cytokine that is the target of the powerful monoclonal antibodies now marketed for the treatment of psoriasis. Company researchers have shown that AN2728 suppresses the phosphodiesterase 4 (PDE4) enzyme, leading to TNF-alpha inhibition.

"This early-stage trial demonstrated definitive anti-inflammatory activity in humans. We are encouraged that the compound decreases TNF-alpha, a cytokine known to be important in psoriasis, by the inhibition of PDE4, a well-validated anti-inflammatory target," said Karl Beutner, Anacor's chief medical officer. "A topical compound that effectively targets TNF-alpha would have great promise, and we intend to initiate further clinical trials to characterize the clinical utility of this drug in psoriasis and other inflammatory skin diseases."

Psoriatic plaques on each of the 12 patients enrolled in the trial were divided into six sections, and each of those sections was treated with a different therapy: AN2728 ointment, AN2728 cream, betamethasone, tacrolimus (Protopic) and vehicle cream and ointment. Using ultrasound, researchers measured the thickness of the inflammatory infiltrate in the psoriatic plaques and also recorded the clinical response based on an investigator global evaluation of disease severity.

As measured by decreases in the thickness of the
'"/>




Page: 1 2

Related medicine technology :

1. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
2. Genetic Analysis Systems Enter the Clinical Mainstream
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:5/22/2013)... 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), ... today that the Company will present at the Stifel Dental ... the Le Parker Meridian hotel, 119 W. 56 th ... presentation is scheduled to begin at 2:15 p.m. Eastern Time ... Heska Corporation (NASDAQ: HSKA - News) sells ...
(Date:5/22/2013)... Conn. , May 22, 2013 /PRNewswire-iReach/ -- ... stay aligned with the latest trends and events, ... that can predict where an industry is headed ... evolve. (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... partnership with market research publisher GlobalData, offer decision ...
(Date:5/22/2013)... May 22, 2013   Accuray Incorporated (Nasdaq: ... is scheduled to present at the 2013 Jefferies Global ... on Thursday, June 6, 2013 at 1:30 p.m. EDT/10:30 ... presentation will be available online from the Investor Relations ... The webcast replay of the presentation will begin ...
Breaking Medicine Technology:Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4
... 15 Researchers at the Barbara,Ann Karmanos Cancer ... developed a HER2 DNA vaccine that has shown ... The study was reported in the September 15 ... Association for Cancer,Research., ( http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSCANCERINSTITUTELO ,GO), ...
... women each year than all cancers combined. Although ... patients, the,unique risk factors and symptoms of female ... disease particularly challenging., Data from the WOMEN ... in WomeN presented today at the American Society ...
Cached Medicine Technology:DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers 2What is the Optimal Method of Ischemia Evaluation in WomeN: Preliminary Data from the WOMEN Study 2
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay ... be at increased risk for cancers of the throat ... drink alcohol, a new study says. Interestingly, common ... prescription medications such as Prilosec, Nexium and Prevacid didn,t, ... about whether heartburn contributes to cancers of the larynx ...
(Date:5/23/2013)... of support for war influences soldier PTSD , ... heightened risk for developing post-traumatic stress disorder if public ... recent research. Social validation or invalidation shapes the level ... the researchers say. The study involved two experiments that ... grinder in one, having an actor show either ...
(Date:5/23/2013)... at Henry Ford Hospital found "substantial evidence" that a ... cord could hold the key to better functional recovery ... hope to those who suffer stroke, the leading cause ... recover some ability to voluntarily use their hands and ... on one side of their bodies, while a substantial ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 ... of home health and hospice software solutions, and ... study that showed significant reductions in rehospitalization rates ... Cornell’s Depression Carepath protocol incorporated into CareAnyware’s EMR ... the study, which included a 39% reduction in ...
(Date:5/23/2013)... positively associated with cancers of the throat and ... use of antacids, but not prescription medications, had ... Cancer Epidemiology, Biomarkers & Prevention , a ... , "Previous studies examining gastric reflux and cancers ... results," said Scott M. Langevin, Ph.D., postdoctoral research ...
Breaking Medicine News(10 mins):Health News:Chronic Heartburn May Raise Odds for Throat Cancer: Study 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 2Health News:Link between war support and PTSD, time it late in negotiations and courtship by narcissists 3Health News:Regenerating spinal cord fibers may be treatment for stroke-related disabilities 2Health News:Regenerating spinal cord fibers may be treatment for stroke-related disabilities 3Health News:CareAnyware and Cornell University Partner to Help Reduce Rehospitalizations by 39% in Clinically Depressed Home Health Patients 2Health News:CareAnyware and Cornell University Partner to Help Reduce Rehospitalizations by 39% in Clinically Depressed Home Health Patients 3Health News:Frequent heartburn may predict cancers of the throat and vocal cord 2
... 30 Melanoma, the most serious form of,skin ... all skin cancer deaths.,Despite repeated health warnings based ... is the most preventable cause of all skin,cancers, ... from this known carcinogen. Now, new understanding of ...
... give their hair a break by limiting use ... popular hair device, CHICAGO, July 30 While hairstyles ... by scores of,loyal fans from coast to coast appears to ... which are used to straighten hair, has increased,in popularity in ...
... guacamole doubles as healthy snack and safe food choice ... the release of the,2000 School Health Policies and Programs ... from America,s schools. This fall, with,Salmonella outbreaks unresolved, picking ... in children,s lunch boxes will be a top concern ...
... of Life-Saving Cord Blood, DETROIT, July 30 ... a $250,000 multi-year grant,from the J.P. McCarthy Fund of ... McCarthy Cord Stem Cell Bank. The grant, which,will be ... enhance the,collection area and expand the capacity to help ...
... extract of Indian herbal remedy showed improved mobility in ... News) -- Frankincense may help reduce the symptoms of ... An enriched extract of the "Indian Frankincense" herb ... placebo-controlled study. Patients who took the herbal remedy showed ...
... The American Journal of Nursing ( AJN ... 2008 Clarion Award, two American Society of Healthcare Publications Editors ... is the largest circulating nursing journal in the world, ... Wolters Kluwer Health, a leading provider of information and business ...
Cached Medicine News:Health News:New Research on Genetic Changes in Melanomas and Teens' Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 2Health News:New Research on Genetic Changes in Melanomas and Teens' Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 3Health News:New Research on Genetic Changes in Melanomas and Teens' Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 4Health News:American Academy of Dermatology: Dermatologists Warn Ceramic Flat Irons Could Damage Hair and Lead to Hair Breakage 2Health News:American Academy of Dermatology: Dermatologists Warn Ceramic Flat Irons Could Damage Hair and Lead to Hair Breakage 3Health News:Back to School Resolution: Practice Food Safety and Healthier Eating 2Health News:J.P. McCarthy Fund Grants $250,000 to Karmanos Cancer Institute 2Health News:J.P. McCarthy Fund Grants $250,000 to Karmanos Cancer Institute 3Health News:J.P. McCarthy Fund Grants $250,000 to Karmanos Cancer Institute 4Health News:Frankincense Provides Relief for Osteoarthritis 2Health News:AJN honored Clarion, 2 ASHPE and 4 Magnum Opus Awards 2Health News:AJN honored Clarion, 2 ASHPE and 4 Magnum Opus Awards 3
The ArthroPasser easily passes any type of suture through tissue and its smooth jaw assists in eliminating,suture fraying....
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
85 right angled suture passer....
45 right angled suture passer....
Medicine Products: